GC Biopharma has partnered with Körber to implement a large-scale Manufacturing Execution System (MES) project across ...

This designation highlights the potential of Cellino’s automated technology for scaling up high-quality iPSCs to industrialize next-generation regenerative therapies. Autologous ...

The U.S. Food and Drug Administration (FDA) has approved the Biologics License Application (BLA) for Novavax Inc.’s Nuvaxovid.

Lars Fruergaard Jørgensen will step down from his role as CEO of Novo Nordisk. In the meantime, a search for Jørgensen’s ...

The new board will work with Abzena's scientific and commercial leadership to provide strategic guidance and insights.

BioMarin has entered into a definitive agreement to acquire Inozyme Pharma Inc. for a total consideration of approximately ...

Genentech has announced plans to invest more than $700 million in a new 700,000 square foot drug manufacturing facility.

Rznomics Inc., a South Korea-based biopharmaceutical company specializing in RNA-based therapeutics, has entered into a ...

Sanofi is the latest major pharmaceutical company to increase its investments in the U.S., partly in response to President ...

Septerna, Novo Nordisk partner to discover, develop and commercialize oral small molecule medicines for cardiometabolic ...

GSK will acquire Boston Pharmaceuticals’ lead asset, efimosfermin alfa, a phase III-ready investigational specialty medicine.

FAMAR Group, a CDMO, has signed an agreement to acquire a sterile production site in Homburg, Germany, from MiP Pharma.